(Q28241484)
Statements
Phase II/III randomized trial of TCH346 in patients with ALS (English)
R Miller
W Bradley
M Cudkowicz
J Hubble
V Meininger
H Mitsumoto
D Moore
H Pohlmann
D Sauer
M Swash
E Vernotica
TCH346 Study Group
Identifiers
2 references
2 references